Paul Feuerstadt

19PUBLICATIONS
15CO-AUTHORS
Liquid biopsiesCancer diagnosisMicrobial ecologyMedical bacteriologySocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 07, 2026
Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies.

|Nov 17, 2025
Diagnosis and Management of Clostridioides difficile.

Colleen R Kelly, Paul Feuerstadt

|Nov 17, 2025
Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent Clostridioides difficile infection from five prospective clinical trials: an update.

Christine Lee, Paul Feuerstadt, Thomas Louie

|Nov 13, 2025
Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.

Sahil Khanna, David Yoho, Daniel Van Handel

|Jun 30, 2025
Assessment of real-world disease severity in patients with eosinophilic esophagitis in the United States.

Evan S Dellon, Glenn T Furuta, Paul Feuerstadt

|May 05, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial.

Sahil Khanna, David Yoho, Daniel Van Handel

Pageof 4

Frequent Collaborators

3 joint publications

Sahil Khanna

3 joint publications

Whitfield L Knapple

2 joint publications

Robert Orenstein

2 joint publications

Kyle Staller